Hunan Nucien Pharmaceutical Co. Ltd. Class ASSE: 688189

Announcement on Expected Loss in Performance for 2025

Jan 31, 2026 · Issued by Hunan Nucien Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment